2235-0410 Screening compound: N-({N'-[(3E)-1-[(2H-1,3-benzodioxol-5-yl)methyl]-2-oxo-2,3-dihydro-1H-indol-3-ylidene]hydrazinecarbonyl}methyl)-3-bromobenzamide

2235-0410 Screening compound: N-({N'-[(3E)-1-[(2H-1,3-benzodioxol-5-yl)methyl]-2-oxo-2,3-dihydro-1H-indol-3-ylidene]hydrazinecarbonyl}methyl)-3-bromobenzamide
2235-0410 Screening compound: N-({N'-[(3E)-1-[(2H-1,3-benzodioxol-5-yl)methyl]-2-oxo-2,3-dihydro-1H-indol-3-ylidene]hydrazinecarbonyl}methyl)-3-bromobenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2235-0410
N-({N'-[(3E)-1-[(2H-1,3-benzodioxol-5-yl)methyl]-2-oxo-2,3-dihydro-1H-indol-3-ylidene]hydrazinecarbonyl}methyl)-3-bromobenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2235-0410

Molecular Formula

C25H19BrN4O5 (C25 H19 BrN4 O5)

Compound Name

N-({N'-[(3E)-1-[(2H-1,3-benzodioxol-5-yl)methyl]-2-oxo-2,3-dihydro-1H-indol-3-ylidene]hydrazinecarbonyl}methyl)-3-bromobenzamide

IUPAC name

N-({N'-[(3E)-1-[(2H-13-benzodioxol-5-yl)methyl]-2-oxo-23-dihydro-1H-indol-3-ylidene]hydrazinecarbonyl}methyl)-3-bromobenzamide

SMILES

O=C(CNC(c1cccc(Br)c1)=O)N/N=C(\c(cccc1)c1N1Cc(cc2)cc3c2OCO3)/C1=O

InChI

InChI=1S/C25H19BrN4O5/c26-17-5-3-4-16(11-17)24(32)27-12-22(31)28-29-23-18-6-1-2-7-19(18)30(25(23)33)13-15-8-9-20-21(10-15)35-14-34-20/h1-11H,12-14H2,(H,27,32)(H,28,31)

InChI Key

KOGHKRUMEJCPOE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01840048

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

535.35

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.403

Distribution Coefficient, logD

4.402

Water Solubility, LogSw

-4.41

Polar Surface Area

91.176

Acid Dissociation Constant (pKa)

10.11

Base Dissociation Constant (pKb)

-1.46

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.00

2235-0410 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with 2235-0410 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2235-0410?
Check Price and Availability of 2235-0410, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2235-0410 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2235-0410
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2235-0410
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2235-0410 available by request